For COVID-19 vaccine updates, please review our information guide and sign up for Connect. Continue your routine care with us by scheduling an in-person appointment or Video Visit.
Study Name: Ralinepag 303
Study Objective: A Phase 3 open-label extension (OLE) study to evaluate the long-term safety and efficacy of ralinepag in subjects with World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) (ADVANCE Extension)
Key Inclusion Criteria:
Key Exclusion Criteria:
PI: Evelyn Horn, MD
RC: Astrid Carmona, 212 746 2623